Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 4,767 | 4,231 | 3,080 | 3,885 | 3,735 |
| Gross Profit | 4,767 | 4,231 | 3,080 | 3,885 | 3,735 |
| Operating Expenses | 33,451 | 30,224 | 22,780 | 32,221 | 30,057 |
| Operating Income | -28,684 | -25,993 | -19,700 | -28,336 | -26,322 |
| Interest Expense | 0 | 0 | 0 | -1,277 | 0 |
| Other Income | 859 | 983 | 1,186 | 0 | 1,300 |
| Pre-tax Income | -27,825 | -25,010 | -18,514 | -27,059 | -25,022 |
| Income Tax | -741 | -15 | -11 | -7 | 1,139 |
| Net Income Continuous | -27,084 | -24,995 | -18,503 | -27,052 | -26,161 |
| Net Income | $-27,084 | $-24,995 | $-18,503 | $-27,052 | $-26,161 |
| EPS Basic Total Ops | -11.88 | -11.52 | -8.64 | -12.61 | -12.12 |
| EPS Basic Continuous Ops | -11.77 | -11.58 | -8.63 | -12.65 | -12.08 |
| EPS Diluted Total Ops | -11.88 | -11.52 | -8.64 | -12.61 | -12.12 |
| EPS Diluted Continuous Ops | -11.77 | -11.58 | -8.63 | -12.65 | -12.08 |
| EBITDA(a) | $-28,799 | $-26,238 | $-20,124 | $-28,793 | $-26,613 |